# Linalool vs linalool-loaded chitosan nanoparticles in an Aβ-induced rat model of Alzheimer’s disease: A molecular, biochemical, histological, and behavioral study

**Authors:** Mohammad Pakdel, Masoumeh Asle-Rousta, Mehdi Sadegh, Akram Eidi

PMC · DOI: 10.22038/ijbms.2025.88638.19143 · Iranian Journal of Basic Medical Sciences · 2025-01-01

## TL;DR

This study compares linalool and linalool-loaded chitosan nanoparticles in a rat model of Alzheimer's, showing that the nanoparticle form is more effective in reducing disease markers.

## Contribution

The study demonstrates that encapsulating linalool in chitosan nanoparticles enhances its therapeutic potential in Alzheimer’s disease models.

## Key findings

- Both linalool and nano-linalool reduced oxidative stress and neuroinflammation in the hippocampus.
- Nano-linalool was more effective than linalool in reducing amyloid plaque deposition and neuronal death.
- Nano-linalool improved learning and spatial memory more significantly than linalool.

## Abstract

Recent studies have increasingly focused on applying nanotechnology to treat neurodegenerative diseases. In this study, we compared the effects of the monoterpene linalool and linalool-loaded chitosan nanoparticles on key pathological features of Alzheimer’s disease (AD), including oxidative stress, neuroinflammation, neuronal death, amyloid plaque deposition, alterations in tryptophan metabolism, and memory deficit in a rat model of AD.

An intracerebroventricular injection of Aβ42 (10 µg) was used to induce the AD model. Linalool (25 mg/kg) and nano-linalool (25 mg/kg) were administered orally once daily for 30 consecutive days.

Both linalool and nano-linalool significantly reduced malondialdehyde levels and enhanced superoxide dismutase activity in the hippocampus. They also decreased the mRNA levels of monocyte chemoattractant protein-1, inhibited the up-regulation of beta-secretase, reduced amyloid plaque deposition, and attenuated pyramidal neuron death in the CA1 region. Additionally, treatment with both compounds down-regulated indoleamine 2,3-dioxygenase, lowered kynurenine levels, and increased serotonin concentrations in the hippocampus. Although both treatments improved learning and spatial memory in Aβ-injected rats, nano-linalool’s effectiveness was more significant than that of linalool in modulating the molecular, biochemical, and histological parameters.

Encapsulating linalool in chitosan nanoparticles enhances its effectiveness in improving molecular, biochemical, and histological changes in the hippocampus of rat models of AD.

## Linked entities

- **Chemicals:** linalool (PubChem CID 6549), chitosan (PubChem CID 129662530), malondialdehyde (PubChem CID 10964), kynurenine (PubChem CID 846), serotonin (PubChem CID 5202), Aβ42 (PubChem CID 8820)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Ido1 (indoleamine 2,3-dioxygenase 1) [NCBI Gene 66029] {aka Ido, Indo}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 24770] {aka MCP-1, MCP1, Scya2, Sigje}, App (amyloid beta precursor protein) [NCBI Gene 54226] {aka Abeta}
- **Diseases:** amyloid plaque (MESH:D058225), AD (MESH:D000544), neuronal death (MESH:D009410), neuroinflammation (MESH:D000090862), neurodegenerative diseases (MESH:D019636), memory deficit (MESH:D008569)
- **Chemicals:** tryptophan (MESH:D014364), Abeta42 (-), kynurenine (MESH:D007737), malondialdehyde (MESH:D008315), Linalool (MESH:C018584), monoterpene (MESH:D039821), chitosan (MESH:D048271), serotonin (MESH:D012701)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12571177/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12571177/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12571177/full.md

---
Source: https://tomesphere.com/paper/PMC12571177